Content Marketing Facts of Life

Content_Marketing_2Content marketing is enjoying a resurgence, and rightly so, as these days people are inundated with promotional messages, digital and social media advertising and noise. In an environment that is cluttered and filled with distractions, people want to connect on a deeper level with the companies, social organizations and products they choose to have in their lives. And it is in making that deeper connection–where you are really adding value to people’s lives–that content marketing, when done effectively, really stands out among marketing and communications disciplines. Continue reading

Pharmaceutical Industry Diversification: The Right Direction?

Yesterday, Bloomberg announced that Merck KGaA will acquire Sigma-Aldrich, a leading global laboratory supply and drug manufacturing services organization for $17 billion in cash. According to Bloomberg, this most recent deal is part of a broader strategy for Merck KGaA to “reduce its dependence on drug development.”

Continue reading

The Father of Sustainability, Pharmaceutical Marketing and Food Safety

567_theodore_roosevelt_seatedAs an avid student of history since I was young, I have been watching and thoroughly enjoying the Ken Burns series “The Roosevelts: An Intimate History” airing on PBS over the past few weeks. While many people have at least a basic understanding of, and appreciation for, the achievements of Franklin Delano Roosevelt, and his extraordinary wife and First Lady Eleanor Roosevelt, I think that far fewer of us are that knowledgeable about Theodore Roosevelt, simply because his presidency and his lifetime are to us far more distant history. But what a great man Theodore Roosevelt was. Burns’ outstanding program gives us wonderful insights into just how thoroughly modern Teddy Roosevelt was, in terms of really helping to shape our current understanding of sustainability, creating the foundations for today’s corporate America, and ushering in a new era of consumer protection by paving the way for what is today’s Food and Drug Administration.

Continue reading

Wearable Health Devices, Healthcare Costs and Big Data Companies

MedCity News today shared some interesting healthcare technology news: 100 million wearable health devices will be shipped over the next five years, according to ABI Research. This market is booming due in large part to the growing interest in the potential to move non-critical care out of the hospitals and into patient’s homes.

Continue reading

Content Marketing White Paper: SEO Myths to Leave Behind in 2014

The world of search engine optimization (SEO) has changed beyond all recognition. And for the better, I’m pleased to say. Because, thankfully, gone are the days when the “SEO Cowboys” at various agencies roamed free and preyed upon unsuspecting marketing directors, convincing them that they alone had the secret sauce that would boost Google search results and put them at the top of the list. Thanks to the smart people at Google, today search results are all about high quality content. Yet many myths about SEO refuse to die. That’s why we’ve partnered with HubSpot to bring you a free white paper, “17 SEO Myths You Should Leave Behind in 2014.” I encourage you to download it. You’ll find that there is a lot of useful information in there about the many changes in SEO best practices that have occured.
Continue reading

The Pharmaceutical Industry Needs to Find a Third Way

Yesterday, John LaMattina published an excellent story in Forbes looking at a recent round of research failures at pharmaceutical companies including Novo Nordisk, Exelixis and Piramal, and suggesting that these and other high profile research failures spell doom for drug discovery research scientists. From the standpoint of our understanding of the causes of human disease in 2014, which has never been greater, this is both illustrative of how risky the drug discovery process has become for pharmaceutical companies, and tragic because as a result of this the industry is scaling back on investments in early stage research at a time when it would seem they should be investing more. The implications for the pharmaceutical industry, and the patients who need the products they research and develop, are worrying to say the least. I spend a lot of time thinking about the pharmaceutical industry, where it is going, and how it can continue to adapt and be successful in times of great change.

Continue reading

The Power of ‘What If’ to Transform the Agency Business Model

What_IfThroughout history, in the realm of human advancement, innovation, art, science, business–you name it, I believe one of the most powerful catalysts for transformation is a little two-word question: “What if?” It has changed our world in amazing ways. It has sent man to the moon, created entire industries that never existed before, saved lives, created works of art, and more. You could argue that the quest to answer this question is responsible for all human progress and innovation.

Continue reading

Content Marketing Facts and Figures

Content_MarketingAt MANA, we love content marketing. For us, it encompasses all of the things we do for our clients, starting with strategic planning, and including content development and dissemination. From a marketing perspective, it is (when done effectively) multidisciplinary or, to digress for a moment into the world of “agency-speak,” it is integrated. Content marketing brings together traditional media, digital media, inbound and outbound marketing, and of course PESO (paid, earned, shared and owned media).

Continue reading